Q78.3
Progressive diaphyseal dysplasia
Clinical Classification Guidelines
Inclusion Terms
- Camurati-Engelmann syndrome
Medical Intelligence & Overview
Progressive diaphyseal dysplasia, also known as Camurati-Engelmann syndrome, is a rare inherited disorder characterized by abnormal thickening of the long bones, particularly in the shafts (diaphyses). This condition typically manifests during childhood or adolescence and can affect bone strength and function. While the exact cause remains linked to genetic mutations, understanding its features, symptoms, and available treatments can help in managing the disorder effectively.
Causes & Symptoms
Clinical Causes: Genetic mutation affecting the TGF-beta signaling pathway Inheritance pattern typically autosomal dominant, meaning a single copy of the mutated gene can cause the disorder Family history of similar symptoms may be present
Key Symptoms: Bone pain and tenderness, especially in the limbs Increased bone density and thickening of the diaphyseal regions of long bones Muscle weakness or fatigue Joint stiffness or limited range of motion Possible skull and facial bone involvement leading to cranial symptoms In some cases, hearing loss due to sclerotic changes in the skull bones
Diagnostic & Treatment
Diagnosis Path: Diagnosing progressive diaphyseal dysplasia involves a combination of clinical evaluation, radiographic imaging, and genetic testing. Healthcare professionals typically utilize the following methods:
Treatment Protocols: There is no cure for progressive diaphyseal dysplasia, but various treatment strategies can help in managing symptoms and improving quality of life:
Clinical Advice & FAQs
Billing Guidance
Is Q78.3 a billable ICD-10 code?
Yes, Q78.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q78.3?
Clinical documentation must specify the nature of Progressive diaphyseal dysplasia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference